Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

708
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
708
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

1.1K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.1K
Brainstem01:19

Brainstem

4.1K
The brainstem, located inferior to the brain and superior to the spinal cord, serves as a bridge between the cerebrum and the spinal cord. It plays a vital role in relaying information and controlling critical life functions. It comprises three primary regions: the midbrain, pons, and medulla oblongata.
The Midbrain
The midbrain is located beneath the diencephalon and connects the cerebrum with the lower parts of the brain. The cerebral peduncles are prominent midbrain structures that house the...
4.1K
Neural Regulation01:37

Neural Regulation

41.2K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
41.2K
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

907
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
907

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Methylmalonic acid: a new target for Hadamard-edited MRS.

bioRxiv : the preprint server for biology·2026
Same author

Characterising the association between posterior parietal metabolite levels and cortical macrostructure in a cohort spanning childhood to adulthood.

Imaging neuroscience (Cambridge, Mass.)·2026
Same author

Real-time AI integration for MR to detect artifacts and guide pulse sequence adaptations.

bioRxiv : the preprint server for biology·2026
Same author

The Impact and Reliability of Tissue Segmentation on In Vivo Magnetic Resonance Spectroscopy Metabolite Quantification.

Magnetic resonance in medicine·2026
Same author

Exploring White Matter Microstructural Abnormalities Using MRI in Women With Premenstrual Dysphoric Disorder via Brain Connectome.

Journal of magnetic resonance imaging : JMRI·2026
Same author

Myo-inositol elevation as an in vivo marker of reactive gliosis in pediatric Friedreich ataxia: evidence from HERMES-edited MR spectroscopy.

NeuroImage. Clinical·2026

Related Experiment Video

Updated: Nov 12, 2025

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
11:12

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation

Published on: July 16, 2014

22.8K

Upper brainstem GABA levels in Parkinson's disease.

Yulu Song1, Tao Gong1, Muhammad G Saleh2,3

  • 1Department of Imaging and Nuclear Medicine, Shandong Medical Imaging Research Institute, Cheeloo College of Medicine, Shandong University, Jinan, 250021, Shandong, China.

Magma (New York, N.Y.)
|March 21, 2021
PubMed
Summary

Parkinson's disease (PD) is linked to lower levels of gamma-aminobutyric acid (GABA) in the upper brainstem. This study used magnetic resonance spectroscopy (MRS) to find reduced GABA in PD patients compared to healthy individuals.

Keywords:
1H MRSBrainstemGABAMEGA-PRESSParkinson’s disease

More Related Videos

Human Neural Organoids for Studying Brain Cancer and Neurodegenerative Diseases
09:36

Human Neural Organoids for Studying Brain Cancer and Neurodegenerative Diseases

Published on: June 28, 2019

10.2K
Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
08:09

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease

Published on: January 7, 2014

7.7K

Related Experiment Videos

Last Updated: Nov 12, 2025

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
11:12

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation

Published on: July 16, 2014

22.8K
Human Neural Organoids for Studying Brain Cancer and Neurodegenerative Diseases
09:36

Human Neural Organoids for Studying Brain Cancer and Neurodegenerative Diseases

Published on: June 28, 2019

10.2K
Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
08:09

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease

Published on: January 7, 2014

7.7K

Area of Science:

  • Neuroscience
  • Neurology
  • Biochemistry

Background:

  • Parkinson's disease (PD) is a neurodegenerative disorder characterized by dopaminergic pathology.
  • GABAergic neurons in the brainstem are implicated in early PD manifestations.
  • Understanding GABAergic system changes in PD is crucial for disease mechanism insights.

Purpose of the Study:

  • To investigate hypothesis of reduced gamma-aminobutyric acid (GABA) levels in the upper brainstem of PD patients.
  • To compare GABA+ levels between PD patients and healthy controls using edited magnetic resonance spectroscopy (MRS).

Main Methods:

  • 18 Parkinson's disease patients and 18 healthy controls (HCs) were recruited.
  • GABA+-edited MRS was performed on 7.5-ml upper brainstem voxels.
  • Gannet software processed spectra; independent t-tests analyzed group differences.

Main Results:

  • Significantly lower GABA+ levels were observed in the upper brainstem of PD patients (4.57 ± 0.94 mM) compared to HCs (5.89 ± 1.16 mM).
  • The difference in GABA+ levels between groups was statistically significant (p < 0.05).

Conclusions:

  • Reduced upper brainstem GABA+ levels in PD patients suggest a GABAergic deficit.
  • This GABAergic deficit may play a role in the underlying pathology of Parkinson's disease.